These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28282403)

  • 21. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
    Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
    Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines.
    Zeiffer U; Schober A; Lietz M; Liehn EA; Erl W; Emans N; Yan ZQ; Weber C
    Circ Res; 2004 Apr; 94(6):776-84. PubMed ID: 14963004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockout of Low Molecular Weight FGF2 Attenuates Atherosclerosis by Reducing Macrophage Infiltration and Oxidative Stress in Mice.
    Liang W; Wang Q; Ma H; Yan W; Yang J
    Cell Physiol Biochem; 2018; 45(4):1434-1443. PubMed ID: 29466783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.
    Hsu CC; Paik J; Brabb TL; O'Brien KD; Kim J; Sullivan BG; Hudkins KL; Seamons A; Finley JC; Meeker SM; Maggio-Price L
    Comp Med; 2015 Oct; 65(5):369-81. PubMed ID: 26473341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-145 targeted therapy reduces atherosclerosis.
    Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
    Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
    Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
    Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the anti-inflammatory activity of a potent myxomaviral chemokine modulating protein, M-T7, through site directed mutagenesis.
    Bartee MY; Chen H; Dai E; Liu LY; Davids JA; Lucas A
    Cytokine; 2014 Jan; 65(1):79-87. PubMed ID: 24211016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
    Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis.
    Lim S; Lee KS; Lee JE; Park HS; Kim KM; Moon JH; Choi SH; Park KS; Kim YB; Jang HC
    Atherosclerosis; 2015 Nov; 243(1):107-19. PubMed ID: 26363808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells.
    van der Vorst EP; Vanags LZ; Dunn LL; Prosser HC; Rye KA; Bursill CA
    FASEB J; 2013 Apr; 27(4):1413-25. PubMed ID: 23271056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
    Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation.
    Rowinska Z; Koeppel TA; Sanati M; Schelzig H; Jankowski J; Weber C; Zernecke A; Liehn EA
    PLoS One; 2017; 12(2):e0170644. PubMed ID: 28234900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Raj T; Kanellakis P; Pomilio G; Jennings G; Bobik A; Agrotis A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1845-51. PubMed ID: 16709940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
    Hu Q; Zhang XJ; Zhang C; Zhao YX; He H; Liu CX; Feng JB; Jiang H; Yang FL; Zhang CX; Zhang Y
    Hum Gene Ther; 2008 Mar; 19(3):287-299. PubMed ID: 18302511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
    Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
    Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
    Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.